Ipo Transactions in Massachusetts

Klaviyo is a SaaS-based data and marketing platform that accelerates growth for companies by enabling them to leverage their owned marketing channels. Serving more than 265,000 companies worldwide, Klaviyo makes it easy to access, store, analyze, and use transactional and behavioral data to power highly targeted email and advertising campaigns. Klaviyo was founded in 2012 and is based in Boston, Massachusetts.

Summit Partners
Investor
Growth Capital Firm
Boston, Massachusetts
www.summitpartners.com

Shopify
Company
Internet Software and Services
Ottawa, Ontario
www.shopify.com

SharkNinja is a designer, marketer, and distributor of primarily branded home cleaning products. It offers over 50 different appliance products, including products for general cleaning, garment care, and kitchen use. The company markets its products under recognized brand names such as Shark, Euro-Pro, Fantom, Omega, and Bravetti, and maintains longstanding relationships with well-known retailers. SharkNinja was formed in 1994 and is based in Needham, Massachusetts.

CDH Private Equity
Investor
Private Equity Firm
Beijing, China
www.cdhfund.com/index.php/a/lists/catid/169/

Acrivon is a proprietary, streamlined approach to develop patient selection tumor biopsy tests, called OncoSignature tests. Company’s lead molecule ACR-368 is a potent, selective inhibitor of CHK1 and CHK2 which has shown deep durable single agent activity, including complete responses, in a proportion of patients across several Phase 2 studies of platinum-resistant ovarian cancer and in squamous cell cancers, including anal cancer for which FDA has granted orphan drug designation. Acrivon was founded in 2018 and is based in Watertown, Massachusetts.

HBM Partners
Investor
Private Equity Firm
Zug, Switzerland
www.hbmpartners.com

Starry is a manufacturer of Wi-Fi routers and offers wireless Internet service delivered via high-frequency millimeter wave technology. Starry was founded in 2014 and is based in Boston, Massachusetts.

KKR
Investor
Private Equity Firm
New York, New York
www.kkr.com

Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabs™ and common light-chain-based multispecific platforms to empirically identify multispecific and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. Compass Therapeutics company’s lead product candidate, CTX-471, is a fully human agonistic antibody of CD137 and is currently being evaluated in a Phase 1 study in patients who were previously treated with PD-1/PD-L1 checkpoint inhibitors and who subsequently relapsed or progressed after a period of stable disease. Compass Therapeutics was incorporated in 2014 and is based in Boston, Massachusetts.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Xilio Therapeutics is a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Xilio Therapeutics was founded in 2016 and is based in Waltham, Massachusetts.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Pyxis Oncology specializes in developing a differentiated portfolio of biologics, including antibody-drug conjugates (ADCs) and immunotherapies, to improve the lives of patients with difficult-to-treat cancers. Pyxis Oncology was founded in 2018 and is based in Boston, Massachusetts.

HBM Partners
Investor
Private Equity Firm
Zug, Switzerland
www.hbmpartners.com

Toast is a restaurant management platform. Toast powers successful restaurants of all sizes with a technology platform that combines restaurant POS, front of house, back of house and guest-facing technology with a diverse marketplace of third-party applications. Toast was founded in 2012 and is based in Boston, Massachusetts.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Definitive Healthcare is a provider of data and intelligence on hospitals, physicians, and other healthcare providers. Definitive Healthcare was founded in 2011 and is based in Framingham, Massachusetts.

22C Capital
Investor
Private Equity Firm
New York, New York
www.22ccapital.com

Advent International
Investor
Private Equity Firm
Boston, Massachusetts
www.adventinternational.com

Spectrum Equity
Investor
Private Equity Firm
Boston, Massachusetts
www.spectrumequity.com

EngageSmart delivers SaaS platforms that drive customer engagement, operational efficiency, and convenient billing and digital payments across multiple vertical end markets. EngageSmart was founded in 2018 and is based in Braintree, Massachusetts.

General Atlantic
Investor
Growth Capital Firm
New York, New York
www.generalatlantic.com

Immuneering is a trusted advisor to pharmaceutical companies, pioneering new analyses to identify biological insights that improve patients’ lives. Immuneering’s team of experts provides advanced data analysis services using state-of-the-art technologies including proprietary algorithms. The company is a rapidly growing company with seven years of experience analyzing data sets ranging from gene expression (microarray) data, to single-nucleotide polymorphism (SNP) data, to protein concentration data, to clinical metadata, to next-generation sequencing (NGS) data including RNA seq, exome sequencing, and whole-genome sequencing. Using these data sets, Immuneering captures difficult-to-find signals, generates biological hypotheses, and designs follow-up studies, contributing to the development of medicines for patients with a wide range of serious diseases. Immuneering was formed in 2008 and is based in Cambridge, Massachusetts.

Teva Pharmaceutical Industries
Company
Life Science
Tel Aviv, Israel
www.tevapharm.com

Rapid Micro Biosystems is a life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Rapid Micro Biosystems was founded in 2006 and is based in Lowell, Massachusetts.

TPG
Investor
Private Equity Firm
Fort Worth, Texas
www.tpg.com

Monte Rosa Therapeutics is a biotechnology company developing molecular glues to degrade disease-causing proteins. The company has developed a platform to rationally design small molecules that reprogram ubiquitin ligases to eliminate disease drivers previously deemed undruggable. The company’s drug discovery platform combines diverse and proprietary chemical libraries of small molecule protein degraders with in-house proteomics, structural biology, machine learning-based target selection, and computational chemistry capabilities to predict and obtain protein degradation profiles. Monte Rosa Therapeutics was founded in 2018 and is based in Boston, Massachusetts.

Aisling Capital
Investor
Private Equity Firm
New York, New York
www.aislingcapital.com

HBM Partners
Investor
Private Equity Firm
Zug, Switzerland
www.hbmpartners.com

Verve Therapeutics is a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. Verve Therapeutics was founded in 2018 and is based in Cambridge, Massachusetts.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Flywire Payments is a provider of global payment and receivables solutions, connecting over 1,400 businesses and institutions with their customers on six continents. The company processes billions in payments per year from 220 countries and territories, via bank transfer, credit card and e-wallet solutions, in over 120 different local currencies. Flywire’s scalable platform provides currency conversion at exchange rates that can offer significant savings when compared to home-market banks and credit card providers. The company also supports its clients with end-to-end customer support including multilingual servicing via phone, email, and chat, as well as 24/7 online payment tracking. Flywire Payments was founded in 2009 and is headquartered in Boston, Massachusetts with operations in London and Manchester, UK; Shanghai, China; Tokyo, Japan; Singapore; Sydney, Australia; and Valencia, Spain.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Werewolf Therapeutics is an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments designed to focus the body's immune response to selectively target cancer. Werewolf's proprietary PREDATOR™ protein engineering platform combines a variety of approaches to actively silence the drug while in systemic circulation, optimize its pharmacokinetic profile, and rapidly and efficiently transform into the fully active state upon reaching the tumor microenvironment for maximum therapeutic potential. Werewolf is creating a new era of tumor-selective, systemically delivered drugs with the potential to deliver more effective, less toxic treatments for people with cancer. Werewolf Therapeutics was founded in 2017 and is based in Watertown, Massachusetts.

HBM Partners
Investor
Private Equity Firm
Zug, Switzerland
www.hbmpartners.com